Supreme Court to Hear Bayer’s Urgent Appeal on Roundup Lawsuits

UPDATE: The Supreme Court has just announced it will hear Bayer’s urgent appeal regarding thousands of lawsuits tied to its widely used weedkiller, Roundup. This pivotal case could determine whether state-level claims can proceed against the agrochemical giant, accused of failing to warn consumers about potential cancer risks associated with its product.

The Supreme Court’s decision comes amidst a growing legal battle, with Bayer facing approximately 181,000 lawsuits from users who allege that Roundup’s key ingredient, glyphosate, is linked to cancer. The announcement was made on October 6, 2023, and the court will consider a specific case from Missouri, where a jury awarded $1.25 million to a man diagnosed with non-Hodgkin’s lymphoma after using Roundup.

Bayer disputes these cancer claims but has set aside a staggering $16 billion to settle cases, highlighting the financial stakes involved. The Environmental Protection Agency (EPA) previously approved Roundup without a cancer warning, a key point in Bayer’s defense, as the company argues that compliance with federal regulations should limit its liability under state laws.

In a twist, the Trump administration has sided with Bayer, reversing the Biden administration’s stance and complicating the legal landscape. This alignment raises questions among supporters of the Make America Healthy Again agenda, many of whom oppose granting Bayer the legal immunity it seeks.

Environmental advocates are alarmed by the Supreme Court’s agreement to consider the case. “It’s a sad day in America when our highest court agrees to consider depriving thousands of Roundup users suffering from cancer of their day in court,” stated Lori Ann Burd, environmental health director at the Center for Biological Diversity.

Bayer has halted the sale of glyphosate in Roundup for residential use in the U.S. but continues to use it in agricultural products designed for genetically modified crops. This strategy allows farmers to increase production while minimizing soil disruption. However, Bayer has warned that it may need to withdraw glyphosate from U.S. agricultural markets if litigation continues to escalate.

The Supreme Court’s deliberations could take place as early as spring 2024, or potentially at the start of the next court term in October 2024. As this legal showdown unfolds, the implications for both Bayer and consumers are profound—impacting not just the company’s future but also the lives of those affected by its products.

Stay tuned for more updates on this developing story, as the court’s ruling could reshape the landscape of environmental liability and corporate accountability in the agriculture sector.